Viewing Study NCT05656482



Ignite Creation Date: 2024-05-06 @ 6:24 PM
Last Modification Date: 2024-10-26 @ 2:47 PM
Study NCT ID: NCT05656482
Status: RECRUITING
Last Update Posted: 2023-03-07
First Post: 2022-12-05

Brief Title: Ability of a Cat Food to Reduce Respiratory Symptoms in Cat Allergic Patients
Sponsor: MASK-air SAS
Organization: MASK-air SAS

Study Overview

Official Title: Evaluation of the Ability of a Cat Food to Reduce Respiratory Symptoms in Cat Allergic Patients Pilot Study
Status: RECRUITING
Status Verified Date: 2023-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CATS
Brief Summary: Cat allergy is the most common animal allergy affecting approximately 1 in 5 adults worldwide The prevalence of allergy to furry animals is increasing and cat allergy is a major risk factor for the development of asthma and rhinitis

Fel-d1 is the major feline allergen to which 95 of cat allergic people react All cats produce Fel-d1 regardless of breed age coat type sex or weight Fel-d1 is contained primarily in the saliva and sebum of cats

This allergy manifests itself as allergic rhinitis AR sneezing cold coughing conjunctivitis with watering and itching severe asthma and irritation and swelling of the skin when scratched

A new approach to managing cat allergies is to neutralize the allergens at the source by feeding domestic cats a diet containing anti-Fel-d1 IgY antibodies The purpose of this pilot study is to determine whether feeding domestic cats a food containing an egg product with anti-Fel d1 IgY PRO PLAN LIVECLEAT induces a reduction of allergic symptoms in their owners
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None